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Abstract: Dental biomaterials and natural products represent two of the main growing 
research fields, revealing plant-derived compounds may play a role not only as 
nutraceuticals in affecting oral health, but also in improving physico-chemical properties of 
biomaterials used in dentistry. Therefore, our aim was to collect all available data concerning 
the utilization of plant polysaccharides, proteins and extracts rich in bioactive phytochemicals 
in enhancing performance of dental biomaterials. Although compelling evidences are 
suggestive of a great potential of plant products in promoting material-tissue/cell interface, 
to date, only few authors have investigated their use in development of innovative dental 
biomaterials. A small number of studies have reported plant extract-based titanium implant 
coatings and periodontal regenerative materials. To the best of our knowledge, this review 
is the first to deal with this topic, highlighting a general lack of research findings in an 
interesting field which still needs to be investigated. 
Keywords: plant products; dental biomaterials; coatings; scaffolds; fillers; osseointegration; 
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1. Introduction 
Biomaterial is any material able to interact harmoniously with a biological host and used as a whole 
or as a part of a system which treats, augments, or replaces any tissue, organ, or function of the body.  
In dentistry, several kinds of biomaterials have been proposed to achieve different tasks and 
improving aspects of:  
1. oral rehabilitation in implantology (titanium implants) 
2. periodontal tissue regeneration. 
Biomaterial surface properties regulate host cell and tissue responses to implanted devices, as well 
as biological integration of biomedical prostheses and tissue-engineered constructs [1]. Therefore, the 
biomaterial-host interface represents a key-point in biocompatibility and functionality of devices or 
products interacting with human body, and greatly depends on biomaterial composition and surface 
properties. The latter can be modulated by means of different surface coatings, in order to improve the 
biomaterial-cell/tissue interface [2]. 
Nowadays, a plethora of coatings have been proposed over time, mainly focused on inorganic 
molecules or animal proteins for cell proliferation and differentiation [1–3]. Only recently, plant 
polysaccharides, proteins and extracts rich in bioactive phytochemicals have been investigated in 
enhancing performance of dental biomaterials. However, this approach is a real challenge for dental 
researchers, being just a new-born field, still to be fully investigated. Indeed, only few papers 
considered feasible bioactive plant products for coating of dental material. 
The main goal of this review was to collect, for the first time, all available data on plant products 
used for the development and improvement of innovative dental biomaterials. Search of papers 
investigating these issues was performed using PUBMED and focusing on a period from January 1965 
to February 2012. Only publications in English were considered. At the beginning of each section, a 
brief description of bioactive plant macromolecules and metabolites will be provided, then studies 
concerning the use of these products in dental biomaterials will be reported. 
2. Plant Product-Based Titanium Implant Coatings  
The gold standard for orthopedic and dental implant metals is titanium (Ti) or its alloys, since  
it is inert and provides high strength, stress resistance and relatively low elastic properties to 
biodevices [4,5].  
Titanium dental implant osseointegration is “a process in which a clinically asymptomatic rigid 
fixation of alloplastic material is achieved and maintained in bone during functional loading” [6]. 
Osseointegration is the final goal to pursue, as well as the hallmark of clinical success, allowing long 
term stability and functionality of the device. Implantation of a biomaterial usually stimulates a foreign 
body reaction, usually manifested as phagocyte recruitment and the formation of a fibrous capsule in 
the peri-implant tissue [7,8]. In this condition, titanium is fibrous-integrated and not osseo-integrated, 
significantly affecting the performance of the implant and causing complications that ultimately may 
lead to implant loosening [9].  
With an attempt at achieving faster osseointegration to accelerate the overall treatment process, the 
use of biomimetic agents represents a growing area of research in implant dentistry. Bioactive agents 
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may be applied to coat the titanium implant surface, among others, biocompatible ceramics, bioactive 
proteins, peptide, ions and polymers [1,10], as effective molecules to stimulate bone regeneration over 
Ti. As examples, collagen-I, RGD-peptide, and chondroitin sulfate are some of the protein/peptide 
coatings used to improve its biocompatibility [3,11]. Moreover, a small number of studies reported 
plant carbohydrate titanium implant coatings that are pectins (Table 1).  
Table 1. Plant products studied for the development and improvement of innovative  
dental biomaterials. 
Plant products Biomaterials Applications References 
Malus domestica L. Titanium implant coating Dental implantology In vitro: [12]  
In vivo (rats): [13] 
Cissus 
quadrangularis L. 
Periodontal filler in association 
with hydroxyapatite 
Periodontal regeneration Clinical trial: [14] 
Carthamus 
tinctorius L 
Periodontal filler in association 
with collagen sponge 
Periodontal filler in association 
with polylactide glycolic acid 
bioresorbable barrier 
Periodontal regeneration 
Periodontal regeneration 
In vivo  
(beagle dogs): [15] 
In vivo  
(beagle dogs): [16] 
Glycine max L.  Bone filler  Alveolar bone regeneration In vivo (rabbits): [17] 
2.1. Pectins  
These are large and complex polysaccharides found in the primary plant cell wall and middle 
lamella among contiguous plant cells. Together with hemicellulose molecules, pectins represent the 
main components of the plant cell wall matrix, within which cellulose microfibrils construct a rigid 
lamellar network capable of bearing osmotic stress as well as mechanic stress. Pectins play several 
relevant roles in plant, including mechanical support, physical barrier against pathogens, 
morphological development, fruit ripening and emulsification of plant tissues. Pectins are widely used 
on an industrial scale. In particular, the emulsifying activity is noteworthy, since the hydrocolloidal 
gel-forming property of pectins is widely exploited in the food industry [18]. The ability of pectins to 
gel is due to many negatively-charged sugar units (containing COO− groups) which are prone to bind 
Ca2+ cations. This calcium cross-linking of pectins leads to extensive hydration [19–22]. Pectin gelling 
properties achieved a growing interest from scientific audience due to the possibility of obtaining  
an in situ biocompatible gelling system, for bone tissue engineering [23–25], injectable cell delivery  
system [26] and drug delivery system [27,28]. 
The structural features of pectins depend on plant species and tissue, though some traits are 
common to all these polysaccharides. Two main structural domains can be distinguished, the smooth 
and hairy (or ramified) regions. The former consist of α-1,4-linked D-galacturonic acid residues, some 
of which are esterified on the carboxyl group with methanol yielding either a high-methyl or  
low-methyl homogalacturonan chain (Figure 1). Conversely, the hairy regions contains two alternating 
sugar residues, α-1,4-linked D-galacturonosyl and α-1,2-linked L-rhamnosyl moieties, forming a 
rhamnogalalacturonan-I (RG-I) backbone. Pectins may also contain a complex RG-II component 
attached to the homogalacturonan region [29,30]. In addition to these natural variations, pectin 
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structures can be further modified in vitro by pectinolytic exo- or endoenzymes, consisting of 
commercial, micro-organism-derived enzyme mixtures designed for degrading pectin gels [31,32]. 
Pectin fragments formed by enzymatic treatments consist of modified hairy regions (MHR), which 
may be used in the coating of biomedical devices, according to their chemical, physical and biological 
properties. In particular, MHR fragments can be considered as nanocoatings forming a 6–10 nm thick 
layer covalently linked onto varies surfaces [33–36]. 
Figure 1. Pectins consist if (a) galacturonic acid and (b) methylesterified homogalacturonan 
(see the text for details) [37,38].  
 
Implant failure often appears as a consequence of excessive host reactions at the implanted tissue 
area. Different and partially opposing immunological effects of pectins have been described. Certain 
pectins showed some anti-inflammatory properties in vitro, a promising and favorable trait in medical 
device tuning [39,40]. On the other hand, some pectins promoted in vitro immunological  
responses [41,42]. Interestingly, it was reported that, in some cases, a whole pectin molecule is 
immunologically inert, differently from its degradation fragments [43]. 
Thus, pectins are nowadays under enthusiastic investigation in the biomaterial field as novel 
candidates for soft and hard tissue engineering and dental titanium coating [32,33,35,36,44]. Promising 
in vitro and in vivo results indicate the possibility of using enzymatically modified apple pectin 
fragments as dental implant nano-coatings [13,45]. Biocompatibility of titanium implant materials 
appeared to be improved when coated with two apple-derived MHR molecules (MHR-A and MHR-B). 
MHR were obtained by treating homogenized apple tissues in vitro with commercial pectinolytic 
enzyme mixtures, which allowed to separate the rhamnogalacturonan and homogalacturonan regions 
of a pectin molecule into suspension [45]. A 6–10 nm thick MHR pectin nanocoating on the titanium 
surface was produced by grafting MHRs onto titanium samples by carbodiimide condensation: indeed, 
amino groups, present onto titanium and obtained via allylamine plasma deposition, were covalently 
linked to the carboxyl groups of MHR [45].  
Kokkonen and colleagues conducted a preliminary study on primary rat bone cells (both osteoblasts 
and osteoclasts) and murine preosteoblastic MC3T3-E1 cell line, where the enzymatically modified 
hairy regions (A and B) of apple pectins were covalently attached to tissue culture on polystyrene or 
glass [39]. As described by a previous work, the surface-functionalization was obtained by means of 
aminating plasma deposition process, then coated with MHR using carbodiimide-mediated 
condensation between deposited amino groups and carboxyl groups of MHR [32]. MHR-B coating, in 
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particular, showed a better interaction with cells, if compared to MHR-A, with enhanced bone cell 
proliferation, attachment and differentiation. The most interesting result concerned osteoblast  
paxillin-stained focal adhesions, an indicator of cell attachment to the substrate: clear paxillin spots on 
MHR-B and bone were detectable referring to primary bone osteoblastic cells, since focal adhesions 
were well-formed and abundant [46]. Therefore, the authors assessed the effects of MHR of apple 
pectins on the growth and differentiation of mammalian bone cells, which demonstrated to be sensitive 
to modifications of pectic coatings, preferring rhamnogalacturonans with shorter side chains in 
parameters studied.  
Then, the possibility to modify dental titanium surfaces with pectin nanocoatings was further 
investigated in order to enhance osteoblast differentiation. MC3T3-E1 cell line, primary murine cells 
and human mesenchymal cells (hMC) were cultured on titanium disks, coated with the above reported 
rhamnogalacturonan-rich modified hairy regions (MHR-A and MHR-B) of apple pectins [45]. 
Consistently with their previous paper, Kokkonen et al. reported as MHRs-B and pure titanium (but 
not MHRs-A) seem to be the most favorable for osteoblast cell spreading, as well related to the highest 
abundance of cellular focal adhesions and to an increasing amount of calcium deposition. Moreover, 
after ten day of differentiation, when hMC morphology was fully osteoblastic, cells cultured on 
MHRs-B showed the highest alkaline phosphatase activity, supporting an increased osteoblast 
differentiation. Modified pectic nano-coating in vitro appears to be a promising direction to enhance 
the biocompatibility of bone and dental implants [45]. In particular, the authors explained the higher 
activity of MHRs-B by considering the relationship between cellular preference and surface  
wettability [32,47]: more hydrophobic MHRs-B were markedly more biocompatible than the more 
wettable MHRs-A [48]. 
On this basis, Kokkonen and co-workers investigated the in vivo inflammatory responses of titanium 
implants coated with the same two different apple pectin MHRs (MHRs-A and MHRs-B) [13]. They 
reported, for the first time, that pectin molecule covalent engraftment of cylindrical titanium samples 
was relatively well-tolerated in mammalian tissues in terms of immunological sensitivity. In particular, 
they used histological analysis of the thickness of peri-implant capsule together with the presence of 
macrophages and/or foreign body giant cells as indicators of physiological responses [13]. However, 
the thickness of capsule is just a stromal response rather than a real inflammatory indicator, and it 
needs to be also corroborated by the presence of activated macrophages or foreign body giant cells in 
the capsules. In Sprague-Dawley rats, they reported a thicker capsule around MHR-B implants, after  
1 week of implantation, whereas, after 3 weeks, this difference disappeared. Moreover, the cell profile 
of the capsule was not associated to the presence of foreign body giant cells in any of the samples [13].  
A few activated mononuclear macrophages were observed similarly in all sample types at both time 
points, but interestingly none of these was at the fibrotic capsule area [13]. As the authors suggested, 
these data represent an interesting outcome, since foreign macromolecules of botanical origin could be 
expected to induce strong inflammatory response during continual tissue contact. Instead, these results 
suggested the in vivo tolerability of covalently linked pectins, and the feasibility of pectin-coated 
dental implants for clinical uses. 
However, to date, no result on osseointegration is provided, being the preclinical data limited to soft 
tissue implantation. Even if they are pivotal to highlight the absence of inflammatory response, 
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corroborating the hypothesis of material biocompatibility, they cannot be considered a direct evidence 
of dental rehabilitation utility, but a promising starting point for future research. 
3. Plant Product-Based in Periodontal Regenerative Therapy 
Regenerative periodontal therapy has the final objective “to predictably restore the tooth’s 
supporting periodontal tissues (i.e., new periodontal ligament, new cementum with inserting 
periodontal ligament fibers and new alveolar bone) that have been lost due to periodontal disease or 
dental trauma” [49]. 
Biomimetic molecules have been proposed alone or in association with guided tissue regeneration 
or guided bone regeneration, using biocompatible barriers. The rationale of using this molecules is 
based on their ability to promote growth and differentiation of cells of periodontal apparatus, 
mimicking physiological tooth formation and periodontal attachment development [50]. 
Different functionalizations of scaffold have been proposed, mainly using growth factors and other 
proteins from animal origin, involved in matrix or bone morphogenesis: BMP, bone morphogenetic 
protein; FGF, fibroblast growth factor; EMD, Enamel Matrix Derivative; PDGF, plateled-derived 
growth factor; IGF, insulin-like growth factor; and TGF, transforming growth factor [51]. They were 
tested on both periodontal ligament cells and cementoblasts, on what concerned migration, 
proliferation, differentiation and matrix gene expression: beside their in vitro effects, they were not 
able to regenerate a new cementum and peridodontal ligament in vivo, probably because of (i) the 
diversity of progenitor cells, related to reminiscent periodontal tissues; (ii) the stability of these factors 
in wound area; and (iii) the limited knowledge about the timing of target cell modulation by these 
factors [52–54].  
Some natural products, originating from medicinal and food plants, have been reported to have a 
beneficial role against periodontal disease [55] and in promoting periodontal healing, i.e., Cissus 
quadrangularis, Carthamus tinctorius and Glycine max (Table 1) [56]. 
3.1. Cissus quadrangularis L. 
It is a perennial medicinal plant indigenous to Asia and Africa and belonging to the Vitaceae family. 
C. quadrangularis (Hadjod in Hindi) is a succulent climbing shrub with quadrangular-sectioned stems, 
reaching a height of 1.5 m. In Indian traditional systems of medicine (Ayurveda and Unani), almost 
entire plant (stem, root and shoots) is used to cure various ailments [57]. In particular, stem paste, dry 
root and shoot powder exert powerful fracture-healing properties [58]. Other ethnomedicinal uses 
include the treatment of scurvy, menstrual disorders, hemorrhoids, muscular and joint pains, asthma, 
epistaxis, otorrhoea, burns and wounds [57]. Phytochemical analyses revealed that C. quadrangularis 
contain high amount of vitamin C, β-carotene, tritepenoids, β-sitosterols, iridoids, flavonoids and 
stilbenes, among which quadrangularin A, B, and C (Figure 2) [58,59]. 
The extracts of C. quadrangularis stem showed anti-inflammatory properties [60–62] and were 
used in enhancing osteoblast proliferation, bone fracture healing, ossification of fetal bone and 
increasing the thickness of trabecular bone [63–65]. The exact molecular mechanism involved in  
C. quadrangularis-promoted osteogenesis is still to be elucidated, despite some mechanisms have been 
proposed. Firstly, some evidence suggested an involvement of the Wnt signaling, which plays a 
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significant role in the control of osteoblastogenesis and bone formation [63]. Then, C. quadrangularis 
may also regulate osteoblastic activity by increasing alkaline phosphatase (ALP) activity, likely by the 
MAPK-dependent pathway, and enhancing the mineralization process [66]. Moreover, C. quadrangularis 
extracts were reported to contain steroids, ascorbic acid, carotene and calcium [67]. The phytoestrogenic 
steroids found in C. quadrangularis may be involved in stimulating osteoblastogenesis and may act on 
estrogen receptors of bone cells [63]. 
Figure 2. Bioactive phytochemicals of Cissus quadrangularis L.: (a) quadrangularin A (a 
stilbene dimer arising from resveratrol); (b) picroside I (an iridoid glycoside); (c) pallidol 
(a dimer of the stilbene resveratrol). 
 
The role of C. quadrangularis in periodontal regeneration of intrabony periodontal defects has been 
evaluated, in association with hydroxyapatite bone filler, in a recent pilot clinical trial [68]. The 
authors clinically evaluated, on twenty patients with intrabony defects, the efficacy of a composite 
graft material composed of bovine-derived hydroxyapatite (HA) combined with C. quadrangularis 
(test group), as compared to HA alone (control group), after scaling and root planning treatments.  
At 6 month follow-up, the authors did not observe differences in clinical measurements between the 
two group; they only reported that the test group showed a slight better performance, without a 
statistical difference [68]. On the other hand, they provided evidence of more favorable measurements 
for both treatments if compared to baseline [68].  
To date, no adjunctive benefit seems to be reported by the use of C. quadrangularis in association 
to scaling, root planning and HA, even if a slight improvement can be noted. It is possible that future 
studies, including a larger number of patients, may clarify the potential role of C. quadrangularis as a 
modulator in periodontal regenerative therapy. 
3.2. Carthamus tinctorius L. 
Safflower (Carthamus tinctorius L.) is an annual chrysanthemum plant belonging to the Asteraceae 
family. It is an important oilseed crop cultivated throughout the semiarid regions of the world for its 
high content of linoleic acid. The edible oil derived from the seeds is also rich in α-tocopherol, and its 
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consumption help to lower blood cholesterol. As well, safflower petals also contains red (water-insoluble) 
and yellow (water-soluble) pigments utilized for producing herbal medicines, food colorants, 
cosmetics, textile and natural dyes (Figure 3) [69,70]. The florets of C. tinctorius have been used as a 
remedy for stroke, gynecological disease, coronary heart disease, angina pectoris and hypertension in 
Chinese folk medicine [69]. In Korea, the safflower seed extracts have traditionally been used for the 
promotion of bone formation and the prevention of osteoporosis [15,71]. 
Figure 3. Bioactive phytochemicals of Carthamus tinctorius L.: (a) carthamin (a 
glucosylquinochalcone); (b) carthamidin (a flavonoid arising from chalcone); (c) safflomin 
A (a glucosylquinochalcone).  
 
Only Korean articles are available dealing with the potential beneficial effects of safflower on  
(i) bone formation in rat calvarian bone defects [72,73]; (ii) development of calcification nodules  
in periodontal ligament and osteoblast cells; (iii) mRNA expression of alkaline phosphatase and  
bone sialoprotein [69]. 
In the last two decades, safflower seed extracts have been investigated to treat intrabony defects in 
beagle dogs [15,74]. In the first study, Kim and colleagues evaluated the efficacy of a safflower seed 
extract (SSE) as filler for the regeneration of periodontal tissue, in a preclinical 1-wall intrabony defect 
model in beagle dogs [15]. They considered a defect with only an inter-proximal bony wall which had 
minimal self-healing capacities [53]. After root planning, they compared the use of a safflower seed 
extract added to a collagen sponge (SSE/Col) with phosphate-buffered saline/collagen (buffer control), 
or root planning only (surgical control) [15]. In particular, among the different safflower seed fraction 
extracts, the fraction extracted with water and methanol showed the best activity in the formation of 
calcification nodules in osteoblasts [69]. Histologic and histometric evaluations, at 8 weeks, suggested 
that new alveolar bone formation was significantly higher in the defects receiving SSE/Col than in the 
two control groups; the amount of new cementum was significantly increased in both SSE/Col and 
buffer control groups if compared to the surgical one [15]. 
Using the same experimental set up, the same research group investigated the possibility to associate 
the safflower extract to a bioresorbable barrier membrane composed of copolymer polylactide glycolic 
acid (PLGA) electro-spun non-woven membrane [74]. The PLGA membranes acted as a suitable 
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carrier system for the safflower seed extracts and as a satisfactory barrier membrane. At 8-week 
healing interval, a significant higher amount of new alveolar bone and new cementum was found in the 
sites treated with PGLA barrier, independently from the presence of safflower extract [74]. 
These data agree with the conclusions suggested by Kim and co-workers in considering as surgical 
implantation in 1-wall intrabony defects of a safflower seed extract/collagen sponge may enhance the 
formation of new alveolar bone, though this approach has unpredictable potential for stimulating the 
whole periodontum regeneration [15].  
3.3. Glycine max L. 
Soya (Glycine max L.) is a legume species (Fabaceae) native to East Asia, widely grown for  
its edible bean rich in proteins, carbohydrates (about 40% each), oil (about 18%) and minerals  
(about 2%) [75]. In particular, it is the only plant food that contains all eight essential amino acids [76]. 
Phytoestrogenic isoflavones (such as genistein and daidzein) (Figure 4) are also present in soya beans, 
particularly effective in reducing (i) the proliferation of certain cancer cells; (ii) the activity of some 
immunocompetent cells as well as (iii) of the bone-resorbing cells, the osteoclasts [75]; and  
(iv) inducing the differentiation of the osteoblasts [77]. Low incidence of breast/prostate cancer and 
osteoporosis in eastern populations has been indeed ascribed to the regular dietary intake of soya 
isoflavones [75–77]. Genistein and daidzein are found abundantly in soya as inactive glycosylated 
forms, genistin and daidzin (Figure 4), respectively, which can be readily converted into aglycones, the 
bioactive metabolites, by hydrolysis in body fluids such as human plasma [75]. 
Figure 4. Bioactive phytochemicals of glucine max L. include the isoflavones genistein 
(a), daidzein (b) and their glycosides genistin (c) and daidzin (d), respectively. 
 
Despite the gold standard in bone replacement, to date, is still the autologous bone graft, 
alternatives were proposed because of limited bone graft availability, patient’s morbidity and risk of 
transmittable diseases associated with allografts. A novel biodegradable biomaterial has been obtained 
by simple thermosetting of defatted soya bean curd, produced by a relatively simple and inexpensive 
process and able to enhance tissue regeneration. It was also hypothesized that the immunogenic 
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response potentially elicited by soya bean xenogenic proteins could be counterbalanced by the known 
immunosuppressant activity of isoflavones [78].  
Recently, Santin and colleagues reported as soybean-based biomaterial granules reduced the  
activity of monocytes/macrophages and osteoclasts, whereas osteoblast differentiation was induced  
in vitro [79]. An in vivo study on rabbit found that the implantation of soybean-based granules, after  
8 weeks, produced bone repair with different features from those obtained by healing in a non-treated 
defect [17]. The authors performed a critical size defect on distal femoral canal, mostly constituted of 
trabecular bone and where bone remodeling can be studied both in terms of bone turn-over and 
trabecular morphology: in the test sites, where soybean-based biomaterial was used, trabecular bone 
(or woven bone) was found, with well organized maturing trabeculae, then physiologically replaced by 
lamellar bone after 8 weeks, whilst the control (not-filled) sites showed a large defect, then filled by a 
pseudo-cortical bone [17].  
These data demonstrated the potential of soybean granules in bone regeneration: their intrinsic 
bioactivity, combined with their relatively easy and cost-effective preparation procedures, make them 
suitable candidates as a bone filler in clinical applications. 
4. Conclusions  
Plant-derived products represent novel and interesting candidates for biomaterial applications, 
including dental research fields. Nutraceuticals and phytochemicals can be considered as  
promising aids in improving the bioactivity of biomaterial, as an alternative to pharmaceuticals and 
animal-derived compounds.  
Certainly, as often occurs, there are some advantages and some disadvantages to deal with. 
Due to their botanical origin, the attainment and use of plant products should not raise ethical 
questions. They are usually readily available and economical, most of them are low immunogenic and, 
at low concentration, not toxic by themselves, though still bioactive. On the other hand, some extracts 
and compounds are difficult to obtain, needing long and complex protocols of extraction, chemical 
characterization and isolation, often with a low yield. In some cases, isolating a single compound in 
significant amounts remains a challenge.  
As Table 1 points out, recent literature fails to correlate dental biomaterials to plant products, with 
only four natural compounds investigated. The presence of only one clinical trial, not able to identify 
any additional benefit, in addition to some in vivo studies that do not provide convincing data, does not 
suggest that clinical application is appropriate. It is apparent that there is a general lack of scientific 
investigations in this field which could well be corrected in the next decades, with both biomaterials 
and plant-derived compounds becoming “hot topics”. 
Acknowledgments 
CARIPLO FOUNDATION NutriAl Network: Internationalization and Excellence for the 
Innovation of Food Production and for Knowledge Development in Nutraceutical-Healthy field,  
Grant for the Promotion of Excellence Human Value—University project 2009 (University of  
Piemonte Orientale).  
Coatings 2012, 2  
 
 
189
References 
1. Avila, G.; Misch, K.; Galindo-Moreno, P.; Wang, H.-L. Implant surface treatment using 
biomimetic agents. Implant Dent. 2009, 18, 17–26. 
2. Reyes, C.D.; Petrie, T.A.; Burns, K.L.; Schwartz, Z.; García, A.J. Biomolecular surface coating to 
enhance orthopaedic tissue healing and integration. Biomaterials 2007, 28, 3228–3235. 
3. Le Guéhennec, L.; Soueidan, A.; Layrolle, P.; Amouriq, Y. Surface treatments of titanium dental 
implants for rapid osseointegration. Dent. Mater. 2007, 23, 844–854. 
4. Brunski, J.B. In vivo bone response to biomechanical loading at the bone/dental-implant interface. 
Adv. Dent. Res. 1999, 13, 99–119. 
5. Wennerberg, A.; Albrektsson, T. Effects of titanium surface topography on bone integration: A 
systematic review. Clin. Oral Implant. Res. 2009, 20, S172–S184. 
6. Albrektsson, T.; Brunski, J.; Wennerberg, A. “A requiem for the periodontal ligament” revisited. 
Int. J. Prosthodont. 2009, 22, 120–122. 
7. Clarke, S.A.; Revell, P.A. Integrin expression at the bone/biomaterial interface. J. Biomed. Mater. 
Res. 2001, 57, 84–91. 
8. Kellar, R.S.; Kleinert, L.B.; Williams, S.K. Characterization of angiogenesis and inflammation 
surrounding ePTFE implanted on the epicardium. J. Biomed. Mater. Res. 2002, 61, 226–233. 
9. Roberts, W.E. Bone tissue interface. J. Dent. Educ. 1988, 52, 804–809. 
10. Morra, M. Biochemical modification of titanium surfaces: Peptides and ECM proteins. Eur. Cell 
Mater. 2006, 12, 1–15. 
11. Junker, R.; Dimakis, A.; Thoneick, M.; Jansen, J.A. Effects of implant surface coatings and 
composition on bone integration: A systematic review. Clin. Oral Implant. Res. 2009, 20, S185–S206. 
12. Kokkonen, H.; Cassinelli, C.; Verhoef, R.; Morra, M.; Schols, H.A.; Tuukkanen, J. Differentiation 
of osteoblasts on pectin-coated titanium. Biomacromolecules 2008, 9, 2369–2376. 
13. Kokkonen, H.; Niiranen, H.; Schols, H.A.; Morra, M.; Stenbäck, F.; Tuukkanen, J. Pectin-coated 
titanium implants are well-tolerated in vivo. J. Biomed. Mater. Res. A 2010, 93, 1404–1409. 
14. Jain, A.; Dixit, J.; Prakash, D. Modulatory effects of Cissus quadrangularis on periodontal 
regeneration by bovine-derived hydroxyapatite in intrabony defects: Exploratory clinical trial.  
J. Int. Acad. Periodontol. 2008, 10, 59–65. 
15. Kim, H.-Y.; Kim, C.-S.; Jhon, G.-J.; Moon, I.-S.; Choi, S.-H.; Cho, K.-S.; Chai, J.-K.; Kim, C.-K. 
The effect of safflower seed extract on periodontal healing of 1-wall intrabony defects in beagle 
dogs. J. Periodontol. 2002, 73, 1457–1466. 
16. Song, W.-S.; Kim, C.-S.; Choi, S.-H.; Jhon, G.-J.; Kim, H.-Y.; Cho, K.-S.; Kim, C.-K.; Chai, J.-K. 
The effects of a bioabsorbable barrier membrane containing safflower seed extracts on periodontal 
healing of 1-wall intrabony defects in beagle dogs. J. Periodontol. 2005, 76, 22–33. 
17. Merolli, A.; Nicolais, L.; Ambrosio, L.; Santin, M. A degradable soybean-based biomaterial used 
effectively as a bone filler in vivo in a rabbit. Biomed. Mater. 2010, 5, doi:10.1088/1748-
6041/5/1/015008. 
18. Yapo, B.M. Pineapple and banana pectins comprise fewer homogalacturonan building blocks with 
a smaller degree of polymerization as compared with yellow passion fruit and lemon pectins: 
Implication for gelling properties. Biomacromolecules 2009, 10, 717–721. 
Coatings 2012, 2  
 
 
190
19. Redondo-Nevado, J.; Moyano, E.; Medina-Escobar, N.; Caballero, J.L.; Muñoz-Blanco, J.  
A fruit-specific and developmentally regulated endopolygalacturonase gene from strawberry 
(Fragaria × ananassa cv. Chandler). J. Exp. Bot. 2001, 52, 1941–1945. 
20. Vincken, J.-P.; Schols, H.A.; Oomen, R.J.F.J.; McCann, M.C.; Ulvskov, P.; Voragen, A.G.J.; 
Visser, R.G.F. If homogalacturonan were a side chain of rhamnogalacturonan I. Implications for 
cell wall architecture. Plant Physiol. 2003, 132, 1781–1789. 
21. Bonnin, E.; Dolo, E.; Le Goff, A.; Thibault, J.-F. Characterisation of pectin subunits released by 
an optimised combination of enzymes. Carbohydr. Res. 2002, 337, 1687–1696. 
22. Liu, L.; Won, Y.J.; Cooke, P.H.; Coffin, D.R.; Fishman, M.L.; Hicks, K.B.; Ma, P.X. 
Pectin/poly(lactide-co-glycolide) composite matrices for biomedical applications. Biomaterials 
2004, 25, 3201–3210. 
23. Munarin, F.; Guerreiro, S.G.; Grellier, M.A.; Tanzi, M.C.; Barbosa, M.A.; Petrini, P.; Granja, P.L. 
Pectin-based injectable biomaterials for bone tissue engineering. Biomacromolecules 2011, 12, 
568–577. 
24. Munarin, F.; Giuliano, L.; Bozzini, S.; Tanzi, M.C.; Petrini, P. Mineral phase deposition on pectin 
microspheres. Mat. Sci. Eng.C 2010, 30, 491–496. 
25. Munarin, F.; Petrini, P.; Tanzi, M.C.; Barbosa, M.A.; Granja, P.L. Biofunctional chemically 
modified pectin for cell delivery. Soft Matter 2012, 8, 4731–4739. 
26. Mishra, R.K.; Datt, M.; Pal, K.; Banthia, A.K. Preparation and characterization of amidated pectin 
based hydrogels for drug delivery system. J. Mater. Sci. Mater. Med. 2008, 19, 2275–2280. 
27. Munarin, F.; Petrini, P.; Farè, S.; Tanzi, M.C. Structural properties of polysaccharide-based 
microcapsules for soft tissue regeneration. J. Mater. Sci. Mater. Med. 2010, 21, 365–375. 
28. Ishii, T.; Matsunaga, T. Pectic polysaccharide rhamnogalacturonan II is covalently linked to 
homogalacturonan. Phytochemistry 2001, 57, 969–974. 
29. Willats, W.G.; McCartney, L.; Mackie, W.; Knox, J.P. Pectin: Cell biology and prospects for 
functional analysis. Plant Mol. Biol. 2001, 47, 9–27. 
30. Schols, H.A.; Voragen, A.G.; Colquhoun, I.J. Isolation and characterization of rhamnogalacturonan 
oligomers, liberated during degradation of pectic hairy regions by rhamnogalacturonase. 
Carbohydr. Res. 1994, 256, 97–111. 
31. Schols, H.A.; Vierhuis, E.; Bakx, E.J.; Voragen, A.G. Different populations of pectic hairy 
regions occur in apple cell walls. Carbohydr. Res. 1995, 275, 343–360. 
32. Morra, M.; Cassinelli, C.; Cascardo, G.; Nagel, M.-D.; Della Volpe, C.; Siboni, S.; Maniglio, D.; 
Brugnara, M.; Ceccone, G.; Schols, H.A.; et al. Effects on interfacial properties and cell adhesion 
of surface modification by pectic hairy regions. Biomacromolecules 2004, 5, 2094–2104. 
33. Nagel, M.-D.; Verhoef, R.; Schols, H.; Morra, M.; Knox, J.P.; Ceccone, G.; Della Volpe, C.; 
Vigneron, P.; Bussy, C.; Gallet, M.; et al. Enzymatically-tailored pectins differentially influence 
the morphology, adhesion, cell cycle progression and survival of fibroblasts. Biochim. Biophys. 
Acta 2008, 1780, 995–1003. 
34. Caffall, K.H.; Mohnen, D. The structure, function, and biosynthesis of plant cell wall pectic 
polysaccharides. Carbohydr. Res. 2009, 344, 1879–1900. 
Coatings 2012, 2  
 
 
191
35. Chen, C.-H.; Sheu, M.-T.; Chen, T.-F.; Wang, Y.-C.; Hou, W.-C.; Liu, D.-Z.; Chung, T.-C.;  
Liang, Y.-C. Suppression of endotoxin-induced proinflammatory responses by citrus pectin 
through blocking LPS signaling pathways. Biochem. Pharmacol. 2006, 72, 1001–1009. 
36. Salman, H.; Bergman, M.; Djaldetti, M.; Orlin, J.; Bessler, H. Citrus pectin affects cytokine 
production by human peripheral blood mononuclear cells. Biomed. Pharmacother. 2008, 62,  
579–582. 
37. Yapo, B.M. Pectic substances: From simple pectic polysaccharides to complex pectins—A new 
hypothetical model. Carbohyd. Polym. 2011, 86, 373–385. 
38. Mohnen, D. Pectin structure and biosynthesis. Curr. Opin. Plant Biol. 2008, 11, 266–277. 
39. Wang, N.L.; Kiyohara, H.; Matsumoto, T.; Otsuka, H.; Hirano, M.; Yamada, H. Polyclonal 
antibody against a complement-activating pectin from the roots of Angelica acutiloba.  
Planta Med. 1994, 60, 425–429. 
40. Sakurai, M.H.; Matsumoto, T.; Kiyohara, H.; Yamada, H. B-cell proliferation activity of pectic 
polysaccharide from a medicinal herb, the roots of Bupleurum falcatum L. and its structural 
requirement. Immunology 1999, 97, 540–547. 
41. Michaelsen, T.E.; Gilje, A.; Samuelsen, A.B.; Høgåsen, K.; Paulsen, B.S. Interaction between 
human complement and a pectin type polysaccharide fraction, PMII, from the leaves of Plantago 
major L. Scand. J. Immunol. 2000, 52, 483–490. 
42. Dourado, F.; Madureira, P.; Carvalho, V.; Coelho, R.; Coimbra, M.A.; Vilanova, M.; Mota, M.; 
Gama, F.M. Purification, structure and immunobiological activity of an arabinan-rich pectic 
polysaccharide from the cell walls of Prunus dulcis seeds. Carbohydr. Res. 2004, 339,  
2555–2566. 
43. Wang, X.-S.; Dong, Q.; Zuo, J.-P.; Fang, J.-N. Structure and potential immunological activity of 
apectin from Centellaasiatica (L.) Urban. Carbohydr. Res. 2003, 338, 2393–2402. 
44. Bussy, C.; Verhoef, R.; Haeger, A.; Morra, M.; Duval, J.-L.; Vigneron, P.; Bensoussan, A.; 
Velzenberger, E.; Cascardo, G.; Cassinelli, C.; et al. Modulating in vitro bone cell and 
macrophage behavior by immobilized enzymatically tailored pectins. J. Biomed. Mater. Res. A 
2008, 86, 597–606. 
45. Kokkonen, H.E.; Ilvesaro, J.M.; Morra, M.; Schols, H.A.; Tuukkanen, J. Effect of modified pectin 
molecules on the growth of bone cells. Biomacromolecules 2007, 8, 509–515. 
46. Bumgardner, J.D.; Wiser, R.; Elder, S.H.; Jouett, R.; Yang, Y.; Ong, J.L. Contact angle, protein 
adsorption and osteoblast precursor cell attachment to chitosan coatings bonded to titanium.  
J. Biomater. Sci. Polym. Ed. 2003, 14, 1401–1409. 
47. Nagel, M.-D.; Verhoef, R.; Schols, H.; Morra, M.; Knox, J.P.; Ceccone, G.; Della Volpe, C.; 
Vigneron, P.; Bussy, C.; Gallet, M.; et al. Enzymatically-tailored pectins differentially influence 
the morphology, adhesion, cell cycle progression and survival of fibroblasts. Biochim. Biophys. 
Acta 2008, 1780, 995–1003. 
48. Sculean, A.; Nikolidakis, D.; Schwarz, F. Regeneration of periodontal tissues: Combinations of 
barrier membranes and grafting materials—Biological foundation and preclinical evidence: A 
systematic review. J. Clin. Periodontol. 2008, 35, 106–116. 
49. Trombelli, L.; Farina, R. Clinical outcomes with bioactive agents alone or in combination with 
grafting or guided tissue regeneration. J. Clin. Periodontol. 2008, 35, 117–135. 
Coatings 2012, 2  
 
 
192
50. Beutner, R.; Michael, J.; Schwenzer, B.; Scharnweber, D. Biological nano-functionalization of 
titanium-based biomaterial surfaces: A flexible toolbox. J. R. Soc. Interface 2010, 7, S93–S105. 
51. Grzesik, W.J.; Narayanan, A.S. Cementum and periodontal wound healing and regeneration.  
Crit. Rev. Oral Biol. Med. 2002, 13, 474–484. 
52. Taba, M., Jr.; Jin, Q.; Sugai, J.V.; Giannobile, W.V. Current concepts in periodontal 
bioengineering. Orthod. Craniofac. Res.2005, 8, 292–302. 
53. Benatti, B.B.; Silvério, K.G.; Casati, M.Z.; Sallum, E.A.; Nociti, F.H., Jr. Physiological features 
of periodontal regeneration and approaches for periodontal tissue engineering utilizing periodontal 
ligament cells. J. Biosci. Bioeng. 2007, 103, 1–6. 
54. Varoni, E.M.; Lodi, G.; Sardella, A.; Carrassi, A.; Iriti, M. Plant polyphenols and oral health: Old 
phytochemicals for new fields. Curr. Med. Chem. 2012, 19, 1706–1720. 
55. Srivastava, K.A.; Mishra, J.N.; Behera, B.R.; Shrivastava, A.K.; Srivastava, P.; Tiwari, B.N.  
A plant (Cissus quadrangularis) with various ethnopharmacological action: A review. J. Pharm. 
Res. 2011, 4, 1887–1890. 
56. Deka, D.K.; Lahon, L.C.; Saikia, J.; Mukit, A. Effect of Cissus quadrangularis in accelerating 
healing process of experimentally fractured radius-ulna of dog, a preliminary study. Indian J. 
Pharmacol. 1994, 26, 44–45. 
57. Mehta, M.; Kaur, N.; Bhutani, K.K. Determination of marker constituents from Cissus 
quadrangularis Linn. and their quantitation by HPTLC and HPLC. Phytochem. Anal. 2001, 12,  
91–95. 
58. Thakur, A.; Jain, V.; Hingorani, L.; Laddha, K.S. Phytochemical Studies on Cissus 
quadrangularis Linn. Pharmacogn. Res. 2009, 1, 213. 
59. Panthong, A.; Supraditaporn, W.; Kanjanapothi, D.; Taesotikul, T.; Reutrakul, V. Analgesic,  
anti-inflammatory and venotonic effects of Cissus quadrangularis Linn. J. Ethnopharmacol.  
2007, 110, 264–270. 
60. Jainu, M.; Mohan, K.V. Protective role of ascorbic acid isolated from Cissus quadrangularis on 
NSAID induced toxicity through immunomodulating response and growth factors expression.  
Int. Immunopharmacol. 2008, 8, 1721–1727. 
61. Srisook, K.; Palachot, M.; Mongkol, N.; Srisook, E.; Sarapusit, S. Anti-inflammatory effect of 
ethyl acetate extract from Cissus quadrangularis Linn may be involved with induction of heme 
oxygenase-1 and suppression of NF-κB activation. J. Ethnopharmacol. 2011, 133, 1008–1014. 
62. Potu, B.K.; Bhat, K.M.R.; Rao, M.S.; Nampurath, G.K.; Chamallamudi, M.R.; Nayak, S.R.; 
Muttigi, M.S. Petroleum ether extract of Cissus quadrangularis (Linn.) enhances bone marrow 
mesenchymal stem cell proliferation and facilitates osteoblastogenesis. Clinics (Sao Paulo) 2009, 
64, 993–998. 
63. Potu, B.K.; Rao, M.S.; Nampurath, G.K.; Chamallamudi, M.R.; Nayak, S.R.; Thomas, H.  
Anti-osteoporotic activity of the petroleum ether extract of Cissus quadrangularis Linn. in 
ovariectomized Wistar rats. Chang Gung Med. J. 2010, 33, 252–257. 
64. Potu, B.K.; Nampurath, G.K.; Rao, M.S.; Bhat, K.M.R. Effect of Cissus quadrangularis Linn on 
the development of osteopenia induced by ovariectomy in rats. Clin. Ter. 2011, 162, 307–312. 
Coatings 2012, 2  
 
 
193
65. Parisuthiman, D.; Singhatanadgit, W.; Dechatiwongse, T.; Koontongkaew, S. Cissus quadrangularis 
extract enhances biomineralization through up-regulation of MAPK-dependent alkaline 
phosphatase activity in osteoblasts. In Vitro Cell. Dev. Biol. Anim. 2009, 45, 194–200. 
66. Aswar, U.M.; Bhaskaran, S.; Mohan, V.; Bodhankar, S.L. Estrogenic activity of friedelin rich 
fraction (IND-HE) separated from Cissus quadrangularis and its effect on female sexual function. 
Pharmacogn. Res. 2010, 2, 138–145. 
67. Emongor, V. Safflower (Carthamus tinctorius L.) the underutilized and neglected crop: A review. 
Asian J. Plant Sci. 2010, 9, 299–306. 
68. Chavan, S.P.; Lokhande, V.H.; Nitnaware, K.M.; Nikam, T.D. Influence of growth regulators and 
elicitors on cell growth and α-tocopherol and pigment productions in cell cultures of Carthamus 
tinctorius L. Appl. Microbiol. Biotechnol. 2011, 89, 1701–1707. 
69. Huh, J.S.; Kang, J.H.; Yoo, Y.J.; Kim, C.S.; Cho, K.S.; Choi, S.H. The effect of safflower seed 
fraction extract on periodontal ligament fibroblast and MC3T3-E1 cell in vitro. J. Korean Acad. 
Periodontol. 2001, 31, 833–846. 
70. Kim, S.T.; Jhon, G.J.; Lim, S.H.; Cho, K.S.; Kim, C.K.; Choi, S.H. The effect of safflower seed 
extract on the bone formation of calvarial bone model in Sprague Dawley rat. J. Korean Acad. 
Periodontol. 2000, 30, 835–850. 
71. You, K.T.; Choi, K.S.; Yun, G.Y.; Kim, E.C.; You, H.K.; Shin, H.S. Healing after implantation of 
bone substitutes and safflower seeds feeding in rat calvarial defects. J. Korean Acad. Periodontol. 
2000, 30, 91–103. 
72. Middleton, E., Jr.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on 
mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev.  
2000, 52, 673–751. 
73. Montgomery, K.S. Soy protein. J. Perinat. Educ. 2003, 12, 42–45. 
74. Perut, F.; Montufar, E.B.; Ciapetti, G.; Santin, M.; Salvage, J.; Traykova, T.; Planell, J.A.; 
Ginebra, M.P.; Baldini, N. Novel soybean/gelatine-based bioactive and injectable hydroxyapatite 
foam: Material properties and cell response. Acta Biomater. 2011, 7, 1780–1787. 
75. Murkies, A.L.; Wilcox, G.; Davis, S.R. Clinical review 92: Phytoestrogens. J. Clin. Endocrinol. 
Metab. 1998, 83, 297–303. 
76. Taku, K.; Melby, M.K.; Nishi, N.; Omori, T.; Kurzer, M.S. Soy isoflavones for osteoporosis: An 
evidence-based approach. Maturitas 2011, 70, 333–338. 
77. Zamora-Ros, R.; Knaze, V.; Luján-Barroso, L.; Kuhnle, G.G.C.; Mulligan, A.A.; Touillaud, M.; 
Slimani, N.; Romieu, I.; Powell, N.; Tumino, R.; et al. Dietary intakes and food sources of 
phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC)  
24-hour dietary recall cohort. Eur. J. Clin. Nutr. 2012, doi:10.1038/ejcn.2012.36. 
78. Friedman, M.; Brandon, D.L. Nutritional and health benefits of soy proteins. J. Agric. Food  
Chem. 2001, 49, 1069–1086. 
  
Coatings 2012, 2  
 
 
194
79. Santin, M.; Morris, C.; Standen, G.; Nicolais, L.; Ambrosio, L. A new class of bioactive and 
biodegradable soybean-based bone fillers. Biomacromolecules 2007, 8, 2706–2711. 
© 2012 by the Authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
